BURL Concepts Secures $4.5 Million Investment
Funding to launch non-invasive SONAS ultrasound system for PFO market
BURL Concepts is proud to announce the closure of a significant funding round totaling $4.5 million, which has garnered considerable interest from both U.S. and international investors focused on MedTech innovation.
This latest influx of capital contributes to a larger investment pool of $28 million that has been raised by BURL Concepts, showcasing the company's potential in transforming the healthcare landscape with cutting-edge technology.
The current investment aims at promoting the rollout of BURL's SONAS ultrasound system, a non-invasive tool designed for assisting healthcare providers in diagnosing patients with Patent Foramen Ovale (PFO). This ultrasound system has received CE marking, attesting to its compliance with European health and safety standards.
Funding will specifically support essential activities such as finalization of FDA regulatory submissions, gaining clinical experience, and initially launching commercialization efforts in Europe and other targeted regions. The SONAS device is heralded as an innovative solution that enables quick and efficient detection of embolic phenomena that can arise in cerebral blood flow.
Peter van der Sluis, CEO of BURL Concepts, highlighted the significance of this fundraising effort, mentioning, "The enthusiastic response to our current funding reflects the market's recognition that a new way to assist physicians in PFO diagnosis for cryptogenic stroke patients is overdue for innovation. We envision PFO testing, similar to standard ECG tests, becoming a routine practice within cardiologists' offices rather than confined to labs or hospitals. With this financing, we can expedite the clinical and commercial introduction of SONAS for brain emboli detection."
Advantages of the SONAS Ultrasound System
The SONAS system introduces revolutionary features that set it apart as a leading diagnostic tool:
Enhanced Patient Convenience
Being a non-invasive test, the SONAS ultrasound can be conducted in a standard doctor's office or even at the bedside, greatly improving accessibility for patients seeking care.
Rapid Results
Routine emboli detection through the SONAS system yields fast results, streamlining the diagnostic process for physicians and assuring timely decision-making.
Cost-Effectiveness
This innovative approach represents a more economical alternative to conventional methods such as transesophageal echocardiography (TEE) or transcranial Doppler (TCD) testing, which often necessitate extensive resources and specialized training.
Automated and User-Friendly
Designed with automation in mind, the SONAS system enables practitioners to perform efficient tests without the need for extensive technical training.
Thilo Hoelscher, MD, Co-Founder and Chief Medical Officer of BURL Concepts, expressed the company’s mission: "We built this company around a simple idea: to provide physicians and patients peace of mind with immediate, actionable insights regarding cerebral blood flow. By leveraging next-generation ultrasound technology combined with proprietary algorithms for signal detection, we aim to empower physicians to swiftly and accurately diagnose PFOs—something that traditional imaging struggles to accomplish."
PFO is a condition characterized by a hole that remains between the left and right atria of the heart, a defect that typically closes at birth but may not in some individuals. Data suggests that approximately 40 to 50% of patients suffering from cryptogenic strokes—those strokes where the cause is not immediately evident—harbor this particular condition.
About BURL Concepts
BURL Concepts, Inc.™, is a pioneering medical technology firm focused on creating rapid and economical solutions for assessing brain perfusion and aiding healthcare professionals in diagnosing Patent Foramen Ovale (PFO). Through its flagship SONAS® technology, BURL Concepts provides a means of non-invasive cerebral blood flow evaluation, enabling informed treatment decisions. For more details, please visit www.burlconcepts.com.
Frequently Asked Questions
What is the purpose of the SONAS ultrasound system?
The SONAS ultrasound system is designed to non-invasively detect abnormalities related to cerebral blood flow, especially in diagnosing Patent Foramen Ovale (PFO).
How does BURL Concepts plan to use the recent funding?
The funding will facilitate final FDA submissions, clinical experience, and initiation of commercialization activities across various markets.
Why is PFO testing important?
Testing for PFO is crucial as it can be linked to cryptogenic strokes, and timely detection can assist in preventing possible complications.
What makes the SONAS system different?
The SONAS system offers a non-invasive, automated, and quicker method for diagnosing PFO, which contrasts with conventional methods requiring extensive resources.
When can healthcare providers expect to implement SONAS?
As BURL Concepts moves forward with commercialization, healthcare providers can anticipate implementation following regulatory approvals and completion of clinical trials.
